Found: 3
Select item for more details and to access through your institution.
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
SGLT2i Use in Non-Diabetics.
- Published in:
- Journal of the Pakistan Medical Association, 2021, v. 71, n. 6, p. 1693
- By:
- Publication type:
- Article
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
- By:
- Publication type:
- Article